The complex role of ZEB1 within AML extends to its effect on the immunological landscape, where it downregulates CD8 T cell activity and promotes the expansion of Th17 cells, enhancing the survival and proliferative capabilities of leukemia cells in the AML niche. This evidence concerns the gene ZEB1 and leukemia.